23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.16%
Negative revenue growth while Insurance - Life median is 1.34%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-7.16%
Negative gross profit growth while Insurance - Life median is 1.28%. Seth Klarman would suspect poor product pricing or inefficient production.
15.83%
EBIT growth exceeding 1.5x Insurance - Life median of 2.53%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
15.83%
Operating income growth exceeding 1.5x Insurance - Life median of 3.88%. Joel Greenblatt would see if unique processes drive exceptional profitability.
17.93%
Net income growth exceeding 1.5x Insurance - Life median of 4.66%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
17.91%
EPS growth exceeding 1.5x Insurance - Life median of 4.67%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
17.93%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 5.08%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
60.40%
OCF growth exceeding 1.5x Insurance - Life median of 9.35%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.
60.40%
FCF growth exceeding 1.5x Insurance - Life median of 9.48%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
84.41%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 30.88%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
13.40%
5Y revenue/share growth 75-90% of Insurance - Life median of 15.38%. John Neff would expect a plan to align with peers or surpass them.
19.93%
3Y revenue/share growth near Insurance - Life median of 18.22%. Charlie Munger would note typical industry expansions over the short term.
100.57%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 10.34% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
-14.96%
Negative 5Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-2.30%
Negative 3Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
41.30%
Net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm that management’s capital allocation strategy drives the outperformance.
-47.35%
Negative 5Y CAGR while Insurance - Life median is 39.04%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
90.22%
3Y net income/share CAGR > 1.5x Insurance - Life median of 40.02%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
24.22%
Equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
9.61%
5Y equity/share CAGR 50-75% of Insurance - Life median. Guy Spier sees subpar net worth creation vs. competitors.
21.97%
3Y equity/share CAGR near Insurance - Life median. Charlie Munger notes it as typical short-term equity expansion in the sector.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.08%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
-0.45%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-1.31%
Negative BV/share change while Insurance - Life median is 4.37%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
-11.28%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-4.44%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.